CIFAR senior fellow co-founds Northern Biologics
A new Canadian biotech company has grown out of cancer research by CIFAR Senior Fellow Jason Moffat and collaborators including Professor Sachdev Sidhu at the University of Toronto, and Benjamin Neel, Robert Rottapel and Bradley Wouters at the Princess Margaret Cancer Centre.
Northern Biologics, announced Dec. 10, received $10 million in backing from Versant Ventures to pursue the development of antibodies and drugs to treat cancer and fibrosis. Moffat, who has been part of CIFAR’s program in Genetic Networks since its inception in 2007, co-founded the company with four other scientists. His research is focused on identifying genes that are essential for cancer cells to grow and divide and uncovering the function of unknown genes through genetic interactions.
“This is a great example of how investing in basic research can pay off in practical applications,” Moffat says, adding that his collaborations with CIFAR Senior Fellows Brendan Frey and Charles Boone (both University of Toronto) were important to the research that led him to co-found the company.
The Globe and Mail published a story about the announcement.
By bringing together researchers across different areas of expertise, including microbiology and anthropology, CIFAR’s Humans & The Microbiome program is...
Roundtable Objectives By bringing together researchers across different areas of expertise, including microbiology and anthropology, CIFAR’s Humans & The Microbiome...